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a,b,c Saudi ArabiaBackground: Excessive coronary calcification can lead to adverse outcomes after percutaneous coronary intervention
(PCI). We therefore evaluated the impact of coronary calcium score (CCS) measured by multidetector computed
tomography (MDCT) on immediate complications of PCI and rate of restenosis.
Methods: We performed a single-center retrospective analysis of 84 patients with coronary stenosis diagnosed by
MDCT who underwent PCI. The Agatston method was used to measure total, target-vessel, and segmental (stent
deployment site) CCS.
Results: In 108 PCI procedures, 32 lesions (29.5%) were American College of Cardiology/American Heart Associ-
ation type A, 60 (55.5%) were type B, and 16 (15%) were type C. ANOVA showed significantly higher segmental CCS
in type C than in type A lesions (29  51 vs. 214  162; p = 0.03). Six patients (7.1%) had periprocedural complications
and seven (8.3%) had in-stent restenosis and angina. Mean total, target-vessel, and segmental CCS was significantly
higher in complicated than in successful PCI (199  325 vs. 816  624, p = 0.001; 92  207 vs. 337  157, p = 0.001; and
79  158 vs. 256  142, p = 0.003, respectively), but there was no significant difference in CCS between successful PCI
and PCI complicated by late restenosis.
Conclusions: CCS measured by MDCT has an important role in predicting early, but not late, complications from
PCI.
 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Abbreviations
BVS bioresorbable vascular scaffold
CCA conventional coronary angiography
CCS coronary calcium score
MDCT multidetector computed tomography
PCI percutaneous coronary intervention
SYNTAX synergy between PCI with TAXUS and cardiac
surgery
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Percutaneous coronary intervention (PCI) isconsidered an effective treatment in selected
patients with symptomatic coronary artery disease
[1–5]. Many factors are associated with procedure
outcome, such as lesion morphology, patient age,
presence of multivessel disease, performance of
an urgent or emergency procedure, and presence
of congestive heart failure class III or IV [6–10].
Excess coronary calcium measured by electron-
beam computed tomography is associated with a
higher rate of unsuccessful percutaneous translu-
minal coronary angioplasty [11]. The presence of
severe coronary calcification assessed by angiog-
raphy in patients with acute coronary syndrome
is associated with higher rates of cardiac death,
ischemic target-lesion revascularization, and
in-stent thrombosis at 1-year follow-up [12]. There
are no clear data regarding the effect of coronary
calcium score (CCS) measured by multidetector
computed tomography (MDCT) on the outcome
of PCI employing a drug-eluting stent. We
hypothesized that increased CCS is associated
with increased immediate and long-term PCI-
related complications.Materials and methods
Study settings and participants
We conducted a retrospective review of 117
patients referred from an outpatient clinic with
nonacute chest pain, who underwent MDCTFigure 1. Study design. CABG = coronary artery bypasses graft; CCA = c
tomography; PCI = percutaneous coronary intervention.between January 2011 and April 2014. These
patients were referred for conventional coronary
angiography (CCA) because of either high CCS
or evidence of significant coronary artery stenosis
by computed tomography angiography. Thirty-
three patients did not undergo PCI because they
had nonsignificant stenosis or coronary artery
bypass graft surgery and were thus excluded;
therefore, the remaining 84 patients, who under-
went PCI for one or more coronary arteries, were
included in our analysis (Fig. 1). Our study took
place at Prince Sultan Cardiac Center Al Qassim
and was approved by the center’s research ethics
committee. Exclusion criteria were a history of
PCI or coronary artery bypass grafting before
MDCT.CT protocol
MDCT was performed using a Siemens Defini-
tion Flash scanner (Siemens Healthcare, Forch-
heim, Germany) with 0.28-second gantry
rotation, 75-ms temporal resolution, and 0.6-mm
collimation. Acquisition started with a scout imageonventional coronary angiography; MDCT = multidetector computed
Figure 2. Multidetector computed tomography noncontrast axial images show the measurement of calcium score of the coronary arteries. (A)
Calcium at the LAD; (B) RCA calcium (red) and LCX (blue); (C) segmental calcification (middle LAD segment); (D) the calcium score of each
coronary artery, total coronary and segmental calcium score. LAD = left anterior descending artery; LCX = left circumflex artery; RCA = right
coronary artery.
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CORONARY CALCIFICATION EFFECTS ON CORONARY INTERVENTIONof the chest to define the field of view. Calcium-
score imaging employed prospective electrocar-
diographic triggering at the best diastolic phase
with 3-mm slice thickness. The images were
reconstructed and analyzed using a multimodality
workplace dedicated CT workstation with VE40A
calcium score software (Siemens Medical Solu-
tions, Forchheim, Germany) to calculate CCS
using the Agatston method [13]. Calcium was
defined as a lesion with a CT density of P130
Hounsfield units and an area of P1 mm2 [13].
The calcium score of each coronary artery, total
coronary calcification, and segmental calcium
score at the sites of stent deployment were
measured (Fig. 2).Coronary angiography and percutaneous
coronary intervention
Standard CCA techniques were used to assess
the left and right coronary systems in multiple
projections. All CCA procedures were performed
using flat-detector technology (Philips Allura Xper
FD10/10 biplane system; Philips, Eindhoven, the
Netherlands). A drug-eluting stent was implanted
in each patient during PCI. No anticoagulation
was used prior to the procedure, although dual
antiplatelet therapy was started immediately priorto the procedure and continued for >12 months.
Patients post stent thrombosis were started on a
double dose of clopidogrel (150 mg) for 1 week
then a regular daily dose of clopidogrel (75 mg)
in addition to aspirin (162 mg daily) for >1 year.
We analyzed percentage vessel stenosis, syn-
ergy between PCI with TAXUS and cardiac sur-
gery (SYNTAX) score, American College of
Cardiology/American Heart Association (ACC/AHA)
classification of lesions (A, B, or C) [14], and angio-
graphic calcium score [ANCS: 0, no calcification; 1,
mild calcification (barely visible on close examina-
tion); 2, moderate calcification (radiopacity noted
only during the cardiac cycle before contrast
injection); and 3, severe calcification (radiopacity
noted with contrast injection and generally involv-
ing both sides of the arterial wall)] [15,16] (Fig. 3).
The interventionist reported the following
parameters: procedure preparation categorized
as easy (direct stenting, single balloon inflation)
or difficult (multiple balloon inflations or use of
Rotablator; Boston Scientific, Marlborough, MA,
USA); durations of fluoroscopy and procedure;
number and length of implanted stents, volume
of contrast injected, final thrombolysis in myocar-
dial infarction grade flow; and procedural compli-
cations such as no reflow, perforation, and
dissection (defined as intimal tears in the arterial
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Figure 3. Angiographic calcium score. (A1) Before and (A2) after contrast injection, showing mild calcification (barely visible on close
examination); (B1 and B2) moderate calcification (radiopacity noted only during the cardiac cycle before contrast injection); (C1 and C2) severe
calcification (radiopacity noted with contrast injection).
18 ABAZID ET AL
CORONARY CALCIFICATION EFFECTS ON CORONARY INTERVENTION
J Saudi Heart Assoc
2017;29:15–22wall post stent deployment that required percuta-
neous management either by the deployment of
further stents or prolonged balloon inflation for
dissection sealing). Periprocedural myocardial
infarction was defined as a more than five-fold
increase above 99th percentile of upper normal
limit in creatine kinase-myocardial band within
24 hours after PCI. Angiographic success was
defined as a final thrombolysis in myocardial
infarction grade flow of 3 and <10% stenosis with
no procedural complications [17]. Late complica-
tions such as stent thrombosis, target-lesion
revascularization, symptoms of angina, heart
failure, and death were reported after 1-year
follow-up.Statistical analysis
Continuous data are presented as mean ± stan-
dard deviation and categorical variables are
expressed as number and percentage. Student t
test was used to analyze the differences between
continuous variables and the chi-square test was
used to compare categorical variables. ANOVA
was used to compare the three different ACC/
AHA lesion types with regard to segmental CCS
and angiographic calcium score. All statistical
analysis was performed using SPSS for Windows,
Version 19.0 (SPSS Inc., Chicago, IL, USA). A p
value of <0.05 was considered statistically signifi-
cant for all tests.
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Table 1 shows patients’ clinical characteristics.
ANOVA comparison of the differences among
the three lesion types showed a significantly
higher calcium score in type C than in type A
lesions (29 ± 51 vs. 214 ± 162; p = 0.03), and a signif-
icantly higher ANCS with more advanced lesions
(Table 2). Periprocedural complications were seen
in six patients (7.1%): coronary dissection in four
(4.8%; three dissections occurred after stentTable 2. Multidetector computed tomography (MDCT) data with a
calcifications.
MDCT data (84 patients)
CCS Agatston score (mean ± SD)
Total 219 ± 337
LM 16 ± 32
LAD 81 ± 117
LCX 43 ± 81
RCA 80 ± 216
CCA data
Lesion type A B
n (%) 32 (29.5) 60 (55.5)
Segmental CCS (mean ± SD) 29 ± 51 94 ± 197
Angiographic calcification 0.7 ± 0.5 1.1 ± 0.6
PCI data
Failed PCI, n (%) 6 (7.1)
Dissection 4
In-stent thrombosis 2
Late complications, n (%) 7 (8.3)
Angina 5
In-stent restenosis 2
Procedure time (min) 38.5 ± 15
Fluoroscopy time (min) 18 ± 7
Contrast (mL) 97 ± 37
Stent number/vessel 1.22 ± 0.46
Stent length (mm) 25.8 ± 12.6
CCA data show prevalence of different American College of Cardiology/Am
graphic score. PCI data shows the procedural success, times and contrast ha
CCA = conventional coronary angiography; CCS = coronary calcium score;
PCI = percutaneous coronary intervention; RCA = right coronary artery; SD
Table 1. Patient characteristics.
Clinical characteristics Patients (n = 84)
Age, mean ± SD (y) 55 ± 12
Male sex, n (%) 55 (65)
Diabetes mellitus, n (%) 40 (48)
Hypertension, n (%) 42 (50)
Dyslipidemia, n (%) 36 (43)
Family history of coronary
artery disease, n (%)
2 (2.4)
Current smoking, n (%) 22 (26)
Body mass index, mean ± SD (kg/m2) 29.2 ± 4.7
SD = standard deviation.deployment and required an additional stent,
and one coronary dissection was associated with
stent delivery failure); and acute in-stent throm-
bosis in two (2.4%). Intravascular ultrasound was
used during the procedure in three patients with
coronary dissection to confirm the presence of a
distal edge flap tear, while neither Rotablator
nor optical coherence tomography were required.
Late complications occurred in eight patients
(8.3%) during a follow-up of 14 ± 6 months: three
(2.4%) had in-stent restenosis and underwent
target-lesion revascularization; and five (5.9%)
had symptoms of angina that were treated
medically (2 patients had evidence of mild ische-
mia by myocardial perfusion imaging). Student t
test analysis was used to compare PCIs with and
without complications and with and without late
complications. Results showed that the total,
target-vessel, and segmental CCS were signifi-
cantly higher when perioperative complications
occurred (816 ± 624 vs.199 ± 325, p = 0.01;
337 ± 157 vs. 92 ± 207, p = 0.001; and 256 ± 142 vs.
79 ± 158, p = 0.003, respectively). In addition,
longer procedure time seen with complicated PCI
(48 ± 14 vs. 37 ± 14 minutes, p = 0.03). However,verage total CCS and the percentage of vessel with detectable
Percentage of detected CCS, n (%)
80 (95.5)
36 (43)
72 (86)
62 (74)
68 (81)
C p
A vs. B A vs. C B vs. C16 (15)
214 ± 162 0.4 0.03 0.16
1.9 ± 0.6 0.047 0.0001 0.007
erican Heart Association type lesions and segmental CCS and angio-
s been used.
LCX = left circumflex; LAD = left anterior descending; LM = left main;
= standard deviation.
Table 3. Comparisons between successful and periprocedure complicated percutaneous coronary intervention (PCI).
Variables Successful PCI (n = 102) Complicated PCI (n = 6) p
No. of patients 78 6
Age, mean ± SD (y) 54 ± 11 60 ± 16 0.2
Male sex, n (%) 50 (64) 5 (83) 0.
Diabetes mellitus, n (%) 37 (47) 3 (37.5) 0.6
Hypertension, n (%) 40 (52) 2 (16.6) 0.3
Dyslipidemia, n (%) 32 (41) 4 (66) 0.2
Family history of coronary artery disease, n (%) 2 (2.5) 0 (0) 0.8
Current smoking, n (%) 19 (24) 3 (50) 0.18
Total CCS, mean ± SD 199 ± 325 816 ± 624 0.01
Target vessel CCS, mean ± SD 92 ± 207 337 ± 157 0.001
Segmental CCS, mean ± SD 79 ± 158 256 ± 142 0.003
Stent length, mean ± SD (mm) 24.6 ± 10.4 27 ± 15 0.1
Number of stents used, mean ± SD 1.2 ± 0.4 1.5 ± 0.85 0.28
Procedure time, mean ± SD (min) 37 ± 14 48 ± 14 0.03
Fluoroscopy time, mean ± SD (min) 17 ± 6 20 ± 7 0.19
Contrast used, mean ± SD (mL) 101 ± 38 93 ± 29 0.12
CCS = coronary calcium score; SD = standard deviation.
Table 4. Comparisons between PCI with and without long-term complications.
Variables No restenosis (n = 101) Late restenosis (n = 7) p
No. of patients 77 7
Age, mean ± SD (y) 54 ± 11 56 ± 16 0.6
Male sex, n (%) 50 (65) 5 (71) 0.54
Diabetes mellitus, n (%) 36 (47) 4 (57) 0.44
Hypertension, n (%) 40 (52) 2 (28.5) 0.2
Dyslipidemia, n (%) 32 (41.5) 4 (57) 0.34
Family history of coronary artery disease, n (%) 2 (2.5) 0 (0) 0.8
Current smoking, n (%) 20 (26) 2 (28.5) 0.59
Total CCS, mean ± SD 200 ± 335 193 ± 190 0.9
Target vessel CCS, mean ± SD 78 ± 163 89 ± 89 0.78
Segmental CCS, mean ± SD 79 ± 158 256 ± 142 0.8
Stent length, mean ± SD (mm) 25 ± 10 23 ± 7 0.23
Number of stents used, mean ± SD 1.2 ± 0.5 1.3 ± 0.3 0.17
Procedure time, mean ± SD (min) 37 ± 14 36 ± 13 0.8
Fluoroscopy time, mean ± SD (min) 17 ± 6 15 ± 3 0.2
Contrast used, mean ± SD (mL) 98 ± 35 106 ± 37 0.2
CCS = coronary calcium score; SD = standard deviation.
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with late complications and complication-free
patients (Tables 3 and 4).Discussion
PCI is widely used to treat patients with signifi-
cant coronary artery stenosis. Despite improve-
ments in PCI technology and pharmacotherapy,
the incidence of periprocedural myocardial infarc-
tion is about 3.5% and is due mostly to procedure
complications such as stent thrombosis and side-
branch occlusion [18]. The complexity of a lesion
plays an important role in the prediction of PCI
outcome; modified-ACC/AHA type C lesions are
associated with lower procedure success ratesand worse clinical outcomes [19]. In fact, the pres-
ence of calcium in an atheroma defines it as an
advanced atherosclerotic lesion [20]. Furthermore,
a lesion’s complexity by modified ACC/AHA clas-
sification and SYNTAX score, which is an anatom-
ical scoring system that can predict major adverse
cardiac events, is determined to a great degree by
the presence of excessive calcification. In addition,
a higher SYNTAX score is associated with a worse
outcome in patients undergoing PCI [21,22].
Rotational atherectomy can overcome extremely
complex lesions with severe calcification by
debulking atherosclerotic plaque before stent
deployment during PCI, but there is conflicting
evidence concerning its benefits [23]. Coronary
calcification can be assessed qualitatively by
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CORONARY CALCIFICATION EFFECTS ON CORONARY INTERVENTIONinvasive CCA using ANCS classification. In con-
trast, intravascular ultrasound is more sensitive
and allows quantitative assessment of arterial cal-
cification [24], and MDCT is a well-established,
noninvasive tool that permits accurate measure-
ment of CCS using the Agatston method [13].
Additionally, MDCT-based coronary angiography
can provide valuable information that can assist
coronary intervention by determining the severity
of stenosis, the extent of calcification, the presence
of multiple stenosis, and reliably estimate lesion
lengths, vessel tortuosity, and the diameter of
distal segments [25].
In the present analysis, we found that the
amount of coronary calcium measured by total,
target vessel, or segmental CCS can significantly
predict periprocedural success and complications
but not restenosis rate. Our results are consistent
with those of a previous report by Wang et al.
[26], which showed that heavy coronary calcifica-
tion assessed by MDCT can predict periprocedu-
ral myocardial infarction in patients undergoing
elective PCI, but which did not include data on
long-term follow up. A similar finding by Sinitsyn
et al. [11] was that the complication rates of percu-
taneous transluminal coronary angioplasty and
PCI were higher with a higher CCS measured by
electron-beam computed tomography. In that
study, however, bare-metal stents were used and
the complication rate higher than in the present
study, in which patients received drug-eluting
stents. Mehran et al. [27] reported that a higher
calcification and plaque burden by preinterven-
tion intravascular ultrasound was associated with
creatine kinase–myocardial band elevation after
coronary intervention. In addition, Genereux
et al. [12] demonstrated that severe calcification
of the coronary target lesion assessed by CCA
can independently predict major bleeding events
after PCI in patients presenting with acute coro-
nary syndrome.
Despite the standard dose of dual antiplatelet
therapy used before the procedure, we observed
a fairly high incidence of acute stent thrombosis
(2.4%), which may be explained by the small num-
ber of patients in the study.
The results of the present study have clinical
implication in patients who have MDCT before
the CCA, the CCS data may help in management
plan when the decision and outcome regarding
PCI versus coronary artery bypass graft is
indistinct.
With increasing use of bioresorbable vascular
scaffold (BVS) during PCI, which requires optimal
(1:1 balloon/vessel) predilatation to improvesscaffold expansion, CCS will probably play
valuable role in predicting optimal predilatation
achievement with BVS. Therefore, we advise
further studies to assess the role of CCS measured
by MDCT before BVS deployment.
Our study had several limitations. First, our
analysis is retrospective. Second, the number of
patients included in the study and the number
of complications was small. Finally, we did not
investigate the effect of noncalcified plaque
burden on the procedure outcome; therefore,
prospective studies with larger numbers of
patients should be conducted and other
computed tomographic angiography data, such
as noncalcified plaque type and burden, should
be collected.Conclusion
Our study showed that increased coronary calci-
fication measured by MDCT is associated with an
increase in immediate PCI complications but did
not predict late complications such as in-stent
restenosis.Conflicts of interest
All authors have no conflicts of interest to
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